期刊文献+

世界卫生组织药品资格预审数据分析

Data Analysis of Current WHO Medicine and Vaccine Prequalification
下载PDF
导出
摘要 对世界卫生组织(WHO)医疗产品资格预审进行简要介绍,并从品种信息与数量、国家或地区分布、国内获批产品及其企业等方面,对当前获批列入WHO资格预审清单中的原料药、化学制剂和疫苗相关数据进行分析与研究,以期为我国制药行业掌握WHO资格预审药品最新市场形势提供借鉴与数据支持,为相关监管机构掌握我国企业参与WHO资格预审情况提供参考。 Based on a brief introduction of World Health Organization(WHO)Prequalification of Medical Products, the study focused on the analysis and research of current data related to APIs, chemical finish products and vaccines approved in Prequalification list. Statistical analysis and discussion were performed from the aspects of product information and quantity, national or regional distribution, approved products and manufacturers in domestic,-etc. It was expected to provide reference and statistical data support about current international drug market related to WHO PQ for pharmaceutical industry, and provided reference for relevant regulatory agencies to understand current situation of domestic manufacturers participated in the WHO prequalification.
作者 颜若曦 YAN Ruo-xi(Center for Food and Drug Inspection of NMPA,Beijing 100044,China)
出处 《中国药物评价》 2023年第1期97-100,共4页 Chinese Journal of Drug Evaluation
关键词 资格预审 化学药品 疫苗 世界卫生组织 Prequalification Medicine Vaccine World Health Organization(WHO)
  • 相关文献

参考文献5

二级参考文献38

  • 1World Health Organization. Procedures for assessing the accepta- bility, in principle, of vaccines for purchase by United Nations agencies ( WHO/BS/10.2155 ) [ EB/OL ]. [ 2012- 06- 01 J. ht- tp://www, who. int/innunazation_standards/vaccine_quality/pq _revision2010/en/.
  • 2World Health Organization. Vaccines prequalification priority list 2013-14 [ EB/OL]. http ://www. who. int/inanunization _ stand- ards/vaceine _ quality/priority_pq vaccines_2013_ 14/en/.
  • 3Global Polio Eradication Initiative. Polio Eradication and ending strategic plan, 2013-2018 [ EB/OL]. http://www, polioeradica- tion. org/ Strat Plan 20130409_ENG. pdf strategyWork/Endgame.
  • 4World Health Organization. ECBS Technical Report Series:vac- cines [ EB/OL ]. http://www, who. int./ bialogicals/publica- tions/trs/areas/vaccines/en/index, html.
  • 5World Health Organization. WHO prequalification: information and guidance documents for vaccine manufactures [ EB/OL ]. http://www, who. int/immunization _ standards/vaccine _ quali- ty/PQ_vaccine manufactures_guidence/en/.
  • 6World Health Organization. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks ( WHO/TRS/978 ) [ EB/OL ]. http://www, who. int/biologi- cals/vaccines/TRS_978_ Annex_3. pdf.
  • 7World Health Organization. Points to consider for manufacturers of human vaccines : clinical considerations for evaluation of vaccines for prequalification [ EB/OL ]. http ://www. who. int/ immuniza- tion _ standards/vaccine _ quality/pq _ vaccine _ evaluation/en/in- dex. html.
  • 8ICH. Comparability of biotechnological/biological products sub- ject to changes in their manufacturing process (CPMP/ICH/ 5721~03 ) [ S]. 2005.
  • 9王家威,马双成.世界卫生组织药品预认证项目的概述及发展方向[J].中国药事,2009,23(4):390-392. 被引量:12
  • 10王莉.印度医药企业的国际化模式及启示——以兰伯西实验室有限公司为例[J].对外经贸实务,2010(7):77-79. 被引量:5

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部